Crosstalk Between The Androgen Receptor And β-Catenin In Castrate-Resistant Prostate Cancer (Medical News Today) PDF Print

UroToday.com - The development of therapeutics for castration resistant prostate cancer depends on understanding the mechanism(s) involved in hormonal progression. The androgen receptor is a transcription factor that is important in the development of both the prostate and prostate cancer.

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.